These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20955208)

  • 1. Assessment of serum sodium to urinary sodium divided by (serum potassium)² to urinary potassium as a screening tool for primary aldosteronism.
    Steichen O; Blanchard A; Plouin PF
    Eur J Clin Invest; 2011 Feb; 41(2):189-94. PubMed ID: 20955208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New index of using serum sodium and potassium and urine sodium and potassium jointly in screening primary aldosteronism in hypertensive patients].
    Yin GS; Zhang SL; Yan L; Li F; Qi YQ; Chen ZC; Cheng H
    Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):962-6. PubMed ID: 20646645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism.
    Willenberg HS; Kolentini C; Quinkler M; Cupisti K; Krausch M; Schott M; Scherbaum WA
    Eur J Clin Invest; 2009 Jan; 39(1):43-50. PubMed ID: 19067735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining body mass index and serum potassium to urine potassium clearance ratio is an alternative method to predict primary aldosteronism.
    Kuo CC; Wu VC; Tsai CW; Huang KH; Wang SM; Li BC; Chang CC; Lu CC; Yang WS; Chao CT; Tsai IC; Lai CF; Lin WC; Wu MS; Lin YH; Lin CY; Chang HW; Wang WJ; Chiang WC; Kao TW; Chueh SC; Chu TS; Tsai TJ; Wu KD;
    Clin Chim Acta; 2011 Aug; 412(17-18):1637-42. PubMed ID: 21621528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma aldosterone to renin ratio predicts treatment response in primary aldosteronism: is volume loading needed?
    Juutilainen AM; Voutilainen ET; Mykkänen L; Niskanen L
    Blood Press; 2005; 14(4):245-50. PubMed ID: 16126559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone-Mediated Sodium Retention Is Reflected by the Serum Sodium to Urinary Sodium to (Serum Potassium)
    Kanaan E; Haase M; Vonend O; Reincke M; Schott M; Willenberg HS
    Diagnostics (Basel); 2020 Jul; 10(8):. PubMed ID: 32751768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Value of Serum Potassium and Ratio of Sodium to Potassium after Saline Infusion Test in Differential Diagnosis of Primary Hyperaldosteronism].
    Du J; Chen T; Li YM; Ren Y; Tian HM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):287-291. PubMed ID: 32543131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.
    Wu VC; Kuo CC; Chang HW; Tsai CT; Lin CY; Lin LY; Lin YH; Wang SM; Huang KH; Fang CC; Ho YL; Liu KL; Chang CC; Chueh SC; Lin SL; Yen RF; Wu KD;
    Clin Chim Acta; 2010 May; 411(9-10):657-63. PubMed ID: 20117105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 11. [The screening of primary aldosteronism with PRA and urinary Na/K after the furosemide test (author's transl)].
    Itoh T; Abe K; Gotoh T; Yoshinaga K
    Nihon Naika Gakkai Zasshi; 1982 Mar; 71(3):312-8. PubMed ID: 7050266
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism.
    Bernini G; Moretti A; Orlandini C; Berti P; Miccoli P; Bardini M; Taurino C; Bernini M; Salvetti A
    J Hypertens; 2008 May; 26(5):981-8. PubMed ID: 18398341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case of primary aldosteronism--considerations on the thiazide screening test].
    Hashimoto T; Sugita K; Narusawa T; Iino S; Niitani H
    Nihon Rinsho; 1968 Apr; 26(4):946-52. PubMed ID: 5693520
    [No Abstract]   [Full Text] [Related]  

  • 14. Morning plasma aldosterone predicts the subtype of primary aldosteronism independent of sodium intake.
    Plamondon I; Agharazii M; Douville P; Lebel M
    Clin Exp Hypertens; 2007 Feb; 29(2):127-34. PubMed ID: 17364612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-evaluation of the fludrocortisone test: duration, NaCl supplementation and cut-off limits for aldosterone.
    Westerdahl C; Bergenfelz A; Larsson J; Nerbrand C; Valdemarsson S; Wihl A; Isaksson A
    Scand J Clin Lab Invest; 2009; 69(2):234-41. PubMed ID: 18951242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Potassium clearance in primary aldosteronism].
    Shioji R; Torigai T
    Saishin Igaku; 1971 Mar; 26(3):548-52. PubMed ID: 5547395
    [No Abstract]   [Full Text] [Related]  

  • 17. Establishment of reference values for endocrine tests. III: Primary aldosteronism.
    Baas SJ; Endert E; Fliers E; Prummel MF; Wiersinga WM
    Neth J Med; 2003 Feb; 61(2):37-43. PubMed ID: 12735419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
    Giacchetti G; Ronconi V; Lucarelli G; Boscaro M; Mantero F
    J Hypertens; 2006 Apr; 24(4):737-45. PubMed ID: 16531803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F;
    J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.